Advertisement
Screener

NEXTCURE, INC (NXTC) Debt Securities, Available-for-sale, Realized Gain

1.4 / 5 stars · 8/29 Roast Me

NEXTCURE, INC Debt Securities, Available-for-sale, Realized Gain

NEXTCURE, INC (NXTC) reported Debt Securities, Available-for-sale, Realized Gain of $0 for the 3-month period ending 2026-06-30, per its S-4 filed 2026-08-18.

Financial Statements › Income Statement › Other Income

us-gaap:DebtSecuritiesAvailableForSaleRealizedGain · last filed 2026-08-18

  • NEXTCURE, INC debt securities, available-for-sale, realized gain for the quarter ending 2026-06-30 was $0.00.
  • NEXTCURE, INC debt securities, available-for-sale, realized gain for the quarter ending 2026-03-31 was $1.00K.
  • NEXTCURE, INC debt securities, available-for-sale, realized gain for the quarter ending 2025-12-31 was $0.00.
  • NEXTCURE, INC debt securities, available-for-sale, realized gain for the quarter ending 2025-09-30 was $0.00.
  • NEXTCURE, INC debt securities, available-for-sale, realized gain for fiscal 2023 was $0.00, a 100.00% decline from fiscal 2022.
  • NEXTCURE, INC debt securities, available-for-sale, realized gain for fiscal 2022 was $9.00K, a 84.21% decline from fiscal 2021.
  • NEXTCURE, INC debt securities, available-for-sale, realized gain for fiscal 2021 was $57.00K, a 18.57% decline from fiscal 2020.
  • NEXTCURE, INC debt securities, available-for-sale, realized gain for fiscal 2020 was $70.00K.
Period endDebt Securities, Available-for-sale, Realized Gain 3 monthDebt Securities, Available-for-sale, Realized Gain 3 month as first filedDebt Securities, Available-for-sale, Realized Gain 6 monthDebt Securities, Available-for-sale, Realized Gain 9 monthDebt Securities, Available-for-sale, Realized Gain 12 month
2026-06-30$0.00
S-4 · filed 2026-08-18
$1.00K
S-4 · filed 2026-08-18
$1.00K
derived: sum of 3 quarters · filed 2026-08-18
$1.00K
derived: sum of 4 quarters · filed 2026-08-18
2026-03-31$1.00K
10-Q · filed 2026-05-07
$1.00K
derived: sum of 2 quarters · filed 2026-08-18
$1.00K
derived: sum of 3 quarters · filed 2026-08-18
$1.00K
derived: sum of 4 quarters · filed 2026-08-18
2025-12-31$0.00
derived: S-4 12 month − 10-Q 9 month · filed 2026-08-18
$0.00
derived: sum of 2 quarters · filed 2026-08-18
$0.00
derived: sum of 3 quarters · filed 2026-08-18
$0.00
S-4 · filed 2026-08-18
2025-09-30$0.00
10-Q · filed 2025-11-05
$0.00
derived: sum of 2 quarters · filed 2026-08-18
$0.00
10-Q · filed 2025-11-05
$0.00
derived: sum of 4 quarters · filed 2026-08-18
2025-06-30$0.00
S-4 · filed 2026-08-18
$0.00
S-4 · filed 2026-08-18
$0.00
derived: sum of 3 quarters · filed 2026-08-18
$0.00
derived: sum of 4 quarters · filed 2026-08-18
2025-03-31$0.00
10-Q · filed 2026-05-07
$0.00
derived: sum of 2 quarters · filed 2026-08-18
$0.00
derived: sum of 3 quarters · filed 2026-08-18
$0.00
derived: sum of 4 quarters · filed 2026-08-18
2024-12-31$0.00
derived: S-4 12 month − 10-Q 9 month · filed 2026-08-18
$0.00
derived: sum of 2 quarters · filed 2026-08-18
$0.00
derived: sum of 3 quarters · filed 2026-08-18
$0.00
S-4 · filed 2026-08-18
2024-09-30$0.00
10-Q · filed 2025-11-05
$0.00
derived: sum of 2 quarters · filed 2025-11-05
$0.00
10-Q · filed 2025-11-05
$0.00
derived: sum of 4 quarters · filed 2025-11-05
2024-06-30$0.00
10-Q · filed 2025-08-07
$0.00
10-Q · filed 2025-08-07
$0.00
derived: sum of 3 quarters · filed 2025-08-07
$0.00
derived: sum of 4 quarters · filed 2025-08-07
2024-03-31$0.00
10-Q · filed 2025-05-01
$0.00
derived: sum of 2 quarters · filed 2025-05-01
$0.00
derived: sum of 3 quarters · filed 2025-05-01
$0.00
derived: sum of 4 quarters · filed 2025-05-01
2023-12-31$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-06
$0.00
derived: sum of 2 quarters · filed 2025-03-06
$0.00
derived: sum of 3 quarters · filed 2025-03-06
$0.00
10-K · filed 2025-03-06
2023-09-30$0.00
10-Q · filed 2024-11-07
$0.00
derived: sum of 2 quarters · filed 2024-11-07
$0.00
10-Q · filed 2024-11-07
$0.00
derived: sum of 4 quarters · filed 2024-11-07
2023-06-30$0.00
10-Q · filed 2024-08-01
$0.00
10-Q · filed 2024-08-01
$0.00
derived: sum of 3 quarters · filed 2024-08-01
$7.00K
derived: sum of 4 quarters · filed 2024-08-01
2023-03-31$0.00
10-Q · filed 2024-05-02
$0.00
derived: sum of 2 quarters · filed 2024-05-02
$7.00K
derived: sum of 3 quarters · filed 2024-05-02
$14.00K
derived: sum of 4 quarters · filed 2024-05-02
2022-12-31$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-21
$7.00K
derived: sum of 2 quarters · filed 2024-03-21
$14.00K
derived: sum of 3 quarters · filed 2024-03-21
$9.00K
10-K · filed 2024-03-21
2022-09-30$7.00K
10-Q · filed 2023-11-02
$0.00
10-Q · filed 2022-11-03
$14.00K
derived: sum of 2 quarters · filed 2023-11-02
$9.00K
10-Q · filed 2023-11-02
$16.00K
derived: sum of 4 quarters · filed 2023-11-02
2022-06-30$7.00K
10-Q · filed 2023-08-03
$9.00K
10-Q · filed 2023-08-03
$9.00K
derived: sum of 3 quarters · filed 2023-08-03
$10.00K
derived: sum of 4 quarters · filed 2023-08-03
2022-03-31$2.00K
10-Q · filed 2023-05-04
$2.00K
derived: sum of 2 quarters · filed 2023-05-04
$3.00K
derived: sum of 3 quarters · filed 2023-05-04
$5.00K
derived: sum of 4 quarters · filed 2023-05-04
2021-12-31$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-02
$1.00K
derived: sum of 2 quarters · filed 2023-03-02
$3.00K
derived: sum of 3 quarters · filed 2023-03-02
$57.00K
10-K · filed 2023-03-02
2021-09-30$1.00K
10-Q · filed 2022-11-03
$3.00K
derived: sum of 2 quarters · filed 2022-11-03
$57.00K
10-Q · filed 2022-11-03
$57.00K
derived: sum of 4 quarters · filed 2022-11-03
2021-06-30$2.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-04
$56.00K
10-Q · filed 2022-08-04
$56.00K
derived: sum of 3 quarters · filed 2022-08-04
2021-03-31$54.00K
10-Q · filed 2022-05-05
$54.00K
derived: sum of 2 quarters · filed 2022-05-05
2020-12-31$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-03
$70.00K
10-K · filed 2022-03-03
2020-09-30$70.00K
10-Q · filed 2021-11-04

Similar stocks

Stock NameCountryMarket CapPE Ratio
TherapeuticsMD, Inc. (TXMD)United States$0.024B-117.87
AYTU BIOPHARMA, INC (AYTU)United States$0.025B-1.62
ARTELO BIOSCIENCES, INC. (ARTL)United States$0.023B
Cocrystal Pharma, Inc. (COCP)United States$0.022B
ATOSSA THERAPEUTICS, INC. (ATOS)United States$0.021B-0.52
KYNTRA BIO, INC. (KYNB)United States$0.028B0.17
Transcode Therapeutics, Inc. (RNAZ)United States$0.029B-0.12
Hepion Pharmaceuticals, Inc. (HEPA)United States$0.029B-0.62
Neuphoria Therapeutics Inc. (NEUP)United States$0.020B-1.77
Marker Therapeutics, Inc. (MRKR)United States$0.020B-2.86